Ebrahim Shafaie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ebrahim Shafaie has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Zoya Tahergorabi
Department of Physiology, School of Medicine, Geriatric Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 shared publications - Bahman Mirzaei
Department of Microbiology and Virology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
1 shared publication - Davood Tasa
Hepatopancreatobiliary Surgery Fellowship Organ Transplantation Group Massih Daneshvari Educational Hospital Shahid Beheshti University of Medical Sciences Tehran Iran sbmu.ac.ir
1 shared publication - Freshteh Osmani
Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
1 shared publication - Gholamreza Hatam
Basic Sciences in Infectious Diseases Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
1 shared publication - Gholamreza Sharifzadeh
Department of Epidemiology and Biostatistics, School of Health, Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
1 shared publication
Latest Publications
- Open Access
- 30 October 2024
- Published by Maad Rayan Publishing Company in Middle East Journal of Digestive Diseases
- Vol. 16 (4) , 230-234
Correlation between Autoimmune Hashimoto’s Thyroiditis and Helicobacter pylori Infection: A Case-Control Study
Background: Among environmental factors, infectious agents, including Helicobacter pylori, can act as triggers for autoimmune thyroid diseases. Therefore, this study aimed to investigate the correlation between autoimmune Hashimoto’s thyroiditis with H. pylori infection. Methods: The participants in this case-control study were 74 individuals 17-62 years who were divided into two groups, including 38 diagnosed Hashimoto’s thyroiditis patients from an outpatient clinic of endocrinology and 36 apparently healthy individuals that were selected from family members of cases group age-matched and sex-matched. For individuals in two groups, a questionnaire was completed, including demographic information. Then, they were referred to the laboratory for thyroid stimulating hormone (TSH) and free T4 (FT4) in the control group and anti-thyroid peroxidase antibody (TPO-Ab) levels measurement in case and control groups. Stool samples were obtained from all individuals for H. pylori antigen detection using the ELIZA kit. Results: There was no significant difference in the mean age of case and control groups (P=0.96), and 81.1% of individuals were female. 58.6% of patients with Hashimoto’s thyroiditis and 41.4% of the control group had positive H. pylori, but there was no statistically significant difference between the two groups (P=0.34). Furthermore, there was a significant positive correlation between TPO-Ab levels and H. pylori infection (r=0.2, P=0.03). Conclusion: TPO-Ab levels were associated with H. pylori infection diagnosed by H. pylori antigen.
- 30 October 2024
- Published by Maad Rayan Publishing Company in Middle East Journal of Digestive Diseases
- Vol. 16 (4) , 230-234
Open AccessCorrelation between Autoimmune Hashimoto’s Thyroiditis and Helicobacter pylori Infection: A Case-Control Study
Background: Among environmental factors, infectious agents, including Helicobacter pylori, can act as triggers for autoimmune thyroid diseases. Therefore, this study aimed to investigate the correlation between autoimmune Hashimoto’s thyroiditis with H. pylori infection. Methods: The participants in this case-control study were 74 individuals 17-62 years who were divided into two groups, including 38 diagnosed Hashimoto’s thyroiditis patients from an outpatient clinic of endocrinology and 36 apparently healthy individuals that were selected from family members of cases group age-matched and sex-matched. For individuals in two groups, a questionnaire was completed, including demographic information. Then, they were referred to the laboratory for thyroid stimulating hormone (TSH) and free T4 (FT4) in the control group and anti-thyroid peroxidase antibody (TPO-Ab) levels measurement in case and control groups. Stool samples were obtained from all individuals for H. pylori antigen detection using the ELIZA kit. Results: There was no significant difference in the mean age of case and control groups (P=0.96), and 81.1% of individuals were female. 58.6% of patients with Hashimoto’s thyroiditis and 41.4% of the control group had positive H. pylori, but there was no statistically significant difference between the two groups (P=0.34). Furthermore, there was a significant positive correlation between TPO-Ab levels and H. pylori infection (r=0.2, P=0.03). Conclusion: TPO-Ab levels were associated with H. pylori infection diagnosed by H. pylori antigen.
- Open Access
- 30 November 2022
- Published by Brieflands in Modern Care Journal
- Vol. 20 (1)
The Comparison of Antimicrobial Effect of New Herbal with Standard Toothpaste with Their Influence on Gingival Health Indexes: A Randomized Clinical Trial
Background: Dental caries, gingivitis, and periodontitis are considered the most common oral and dental health problems in different parts of the world. Objectives: The present study aimed to evaluate the antibacterial activity, plaque index, and gingival index determination of herbal toothpaste compared with standard toothpaste. Methods: The present study is a randomized clinical trial on 60 participants of 18 - 28 years and a minimum of 24 healthy teeth at Birjand Dental School that were randomly divided into two groups, herbal and standard toothpaste (n = 30 each group); only participants were blind. All subjects brushed their teeth for 3 minutes 2 times a day for seven months. The plaque index (PI) and gingival index (GI) for each participant also, saliva samples were taken from the subjects for Streptococcus mutans and Lactobacillus spp., colony count at the onset of the study, and 3, 5, and 7 months after toothpaste usage. Results: This study was conducted on 60 patients in two study groups. No significant statistical difference was observed between age and gender in the two studied groups. Our study showed that the mean number of S. mutans in the two groups was not significantly different (P > 0.05), but the mean number of Lactobacillus spp. in the group of herbal toothpaste at three months (P = 0.02) and seven months (P = 0.002) was significantly less than standard toothpaste. Also, the mean PI and the GI indices in the herbal toothpaste group after use for five months (P = 0.02) (P = 0.03) and seven months (P < 0.001) (P = 0.03), respectively, were significantly lower than standard toothpaste. Conclusions: Throughout the 7-month trial, herbal toothpaste showed higher antimicrobial activity against Lactobacillus spp. than standard toothpaste, effectively reducing dental plaque and gingivitis. Furthermore, no undesirable reactions to toothpaste were reported during the trial. Therefore, it was concluded that possibly novel herbal toothpaste could be an alternative for controlling dental plaque and gingivitis. Further studies are needed.
- 30 November 2022
- Published by Brieflands in Modern Care Journal
- Vol. 20 (1)
Open AccessThe Comparison of Antimicrobial Effect of New Herbal with Standard Toothpaste with Their Influence on Gingival Health Indexes: A Randomized Clinical Trial
Background: Dental caries, gingivitis, and periodontitis are considered the most common oral and dental health problems in different parts of the world. Objectives: The present study aimed to evaluate the antibacterial activity, plaque index, and gingival index determination of herbal toothpaste compared with standard toothpaste. Methods: The present study is a randomized clinical trial on 60 participants of 18 - 28 years and a minimum of 24 healthy teeth at Birjand Dental School that were randomly divided into two groups, herbal and standard toothpaste (n = 30 each group); only participants were blind. All subjects brushed their teeth for 3 minutes 2 times a day for seven months. The plaque index (PI) and gingival index (GI) for each participant also, saliva samples were taken from the subjects for Streptococcus mutans and Lactobacillus spp., colony count at the onset of the study, and 3, 5, and 7 months after toothpaste usage. Results: This study was conducted on 60 patients in two study groups. No significant statistical difference was observed between age and gender in the two studied groups. Our study showed that the mean number of S. mutans in the two groups was not significantly different (P > 0.05), but the mean number of Lactobacillus spp. in the group of herbal toothpaste at three months (P = 0.02) and seven months (P = 0.002) was significantly less than standard toothpaste. Also, the mean PI and the GI indices in the herbal toothpaste group after use for five months (P = 0.02) (P = 0.03) and seven months (P < 0.001) (P = 0.03), respectively, were significantly lower than standard toothpaste. Conclusions: Throughout the 7-month trial, herbal toothpaste showed higher antimicrobial activity against Lactobacillus spp. than standard toothpaste, effectively reducing dental plaque and gingivitis. Furthermore, no undesirable reactions to toothpaste were reported during the trial. Therefore, it was concluded that possibly novel herbal toothpaste could be an alternative for controlling dental plaque and gingivitis. Further studies are needed.
- 1 March 2021
- Published by Galenos Yayinevi in Turkish Journal of Parasitology
- Vol. 45 (1) , 1-4
The Efficacy of Hydroalcoholic Extracts of Prosopis farcta Against Leishmania major
Cutaneous leishmaniasis caused by Leishmania major (L. major) is an endemic disease in Iran. The current reference drugs, including Glucantime, possess high toxicity in addition to some side-effects. Therefore, there is a growing interest in exploring biomedical plants. The goal of the present study was to evaluate the anti-leishmanial activity and cytotoxicity of hydroalcoholic extracts from Prosopis farcta (P. farcta) over promastigote and amastigote forms. This study was performed at the Iran Birjand University of Medical Sciences, during the year 2019. In this study, the hydroalcoholic extracts of the stems, leaves (LE) and fruits (FE) of P. farcta were obtained. The anti-leishmanial activity was assessed against leptomonad promastigotes and intracellular amastigotes of L. major. The cytotoxicity of these extracts was determined in murine macrophages. The FE and LE of P. farcta demonstrated a significant leishmanicidal effect against L. major promastigotes with an IC50 of 0.9 mg/mL and 1.1 mg/mL, respectively. The FE showed the most anti-leishmanial activity and presented with the highest index of selectivity (SI=14.6) as an anti-leishmanial product. Infected macrophages treated using the FE showed a reduction in parasite burden by 97.3%. The results of the present study demonstrated the leishmanicidal activity of P. farcta on both promastigotes and intracellular amastigotes. There is a need for performing comprehensive studies on relevant animal models and to access the effects of active components of P. farcta extract on the growth of L. major.
- 1 March 2021
- Published by Galenos Yayinevi in Turkish Journal of Parasitology
- Vol. 45 (1) , 1-4
The Efficacy of Hydroalcoholic Extracts of Prosopis farcta Against Leishmania major
Cutaneous leishmaniasis caused by Leishmania major (L. major) is an endemic disease in Iran. The current reference drugs, including Glucantime, possess high toxicity in addition to some side-effects. Therefore, there is a growing interest in exploring biomedical plants. The goal of the present study was to evaluate the anti-leishmanial activity and cytotoxicity of hydroalcoholic extracts from Prosopis farcta (P. farcta) over promastigote and amastigote forms. This study was performed at the Iran Birjand University of Medical Sciences, during the year 2019. In this study, the hydroalcoholic extracts of the stems, leaves (LE) and fruits (FE) of P. farcta were obtained. The anti-leishmanial activity was assessed against leptomonad promastigotes and intracellular amastigotes of L. major. The cytotoxicity of these extracts was determined in murine macrophages. The FE and LE of P. farcta demonstrated a significant leishmanicidal effect against L. major promastigotes with an IC50 of 0.9 mg/mL and 1.1 mg/mL, respectively. The FE showed the most anti-leishmanial activity and presented with the highest index of selectivity (SI=14.6) as an anti-leishmanial product. Infected macrophages treated using the FE showed a reduction in parasite burden by 97.3%. The results of the present study demonstrated the leishmanicidal activity of P. farcta on both promastigotes and intracellular amastigotes. There is a need for performing comprehensive studies on relevant animal models and to access the effects of active components of P. farcta extract on the growth of L. major.
- 11 April 2020
- Published by Negah Scientific Publisher in Research in Molecular Medicine
- Vol. 8 (2) , 63-70
Multi-drug Resistant Citrobacter freundii Isolates in a Burn Hospital in Northeast of Iran: A Single-Center Cross-sectional Study
Background: Multi-drug resistant (MDR) Citrobacter freundii (C. freundii) as a causative agent of nosocomial infections is a health threat, especially in hospitals. This study was conducted to determine the prevalence of MDR C. freundii, considering isolation sites and a variety of utilized antibiotics. Materials and Methods: In this cross-sectional study, the clinical samples of C. freundii strains were collected and screened using traditional bacteriological tests in Zareh Hospital, Sari City, Iran, during 2016-2017. We used disk diffusion methods to assess the susceptibility patterns of isolates according to the Clinical Laboratory Standard Institute (CLSI) guidelines. Results: Out of 3248 clinical samples, C. freundii strains were detected in 109 samples (32.1% females and 67.9% males). Susceptibility tests indicated that 89 isolates (81.65%) were MDR strains. Frequencies of MDR C. freundii strains were higher in the Behavioral Intensive Care Unit (BICU) (37.61%) and restoration ward (29.35%) compared with other hospital wards. Conclusion: Considering the MDR C. freundii strains detected from burn hospital wards, it is necessary to implement prevention criteria for their eradication from burn hospitals. The results indicate the urgent need to design more practical methods for controlling infection in hospital wards.
- 11 April 2020
- Published by Negah Scientific Publisher in Research in Molecular Medicine
- Vol. 8 (2) , 63-70
Multi-drug Resistant Citrobacter freundii Isolates in a Burn Hospital in Northeast of Iran: A Single-Center Cross-sectional Study
Background: Multi-drug resistant (MDR) Citrobacter freundii (C. freundii) as a causative agent of nosocomial infections is a health threat, especially in hospitals. This study was conducted to determine the prevalence of MDR C. freundii, considering isolation sites and a variety of utilized antibiotics. Materials and Methods: In this cross-sectional study, the clinical samples of C. freundii strains were collected and screened using traditional bacteriological tests in Zareh Hospital, Sari City, Iran, during 2016-2017. We used disk diffusion methods to assess the susceptibility patterns of isolates according to the Clinical Laboratory Standard Institute (CLSI) guidelines. Results: Out of 3248 clinical samples, C. freundii strains were detected in 109 samples (32.1% females and 67.9% males). Susceptibility tests indicated that 89 isolates (81.65%) were MDR strains. Frequencies of MDR C. freundii strains were higher in the Behavioral Intensive Care Unit (BICU) (37.61%) and restoration ward (29.35%) compared with other hospital wards. Conclusion: Considering the MDR C. freundii strains detected from burn hospital wards, it is necessary to implement prevention criteria for their eradication from burn hospitals. The results indicate the urgent need to design more practical methods for controlling infection in hospital wards.